Introduction to the important announcement concerning SWISS-PROT and
other databases on ExPASy
Increased data flow has created a requirement for resources which cannot be
addressed in full by public funding. This is causing databases to fall behind
the research. We believe that the only solution to the resource shortfall is
to ask commercial users to participate by paying a license fee. No fee will be charged to
academic users, nor will any restriction be imposed on their use or reuse of
the data. The databases available on
ExPASy
that are currently concerned by these
changes are:
SWISS-PROT,
PROSITE and
SWISS-2DPAGE.
SWISS-MODEL
Repository might be affected at a later stage.
ENZYME,
SeqAnalRef
and
CD40Lbase are not concerned by these changes nor are
there any plans to change their status.
Whether you are an academic or a commercial user, we urge you to read the
following documents:
If after having read these documents, you still have questions, you can
send them to the following addresses:
General information:
Licensing information:
Commercial users can also directly contact Geneva Bioinformatics (GeneBio) SA. GeneBio has been
mandated by the
Swiss Institute of Bioinformatics (SIB) to act as their representative for the purpose of concluding the necessary license agreements.
